leftcomputerpost

[leftcomputerpost]

Laboratory Information Systems (LIS) Market will grow at robust CAGR

Global laboratory information system (LIS) market revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the report builds upon the widely cited previous version, and incorporates the latest developments, notably, the impact of COVID-19 pandemic on this market.

Over the years, the healthcare industry has witnessed massive technological advancements in the form of automation, big data analytics and cloud computing. The most important aspect in the industry is the need to reconcile administrative operations with caregiving operations. This has become possible through the introduction of advanced laboratory testing systems.

Laboratories are the foundational stone for primary healthcare administration. It is the laboratories which are the site for drug development and API formulations. To accelerate the effectiveness of these functions, there is a need to streamline mundane operations such as data collation, assimilation and record maintenance.

The need for systematic data documentation to reduce paperwork is primarily driving the laboratory information systems market. Significant adoption has been witnessed since the COVID-19 pandemic’s onset, enabling healthcare providers to concentrate on drug and vaccine development by smoothening data collection procedures.

Key Findings

Europe & North America will remain lucrative, accounting for 4/5th of the revenue pie

Cloud-based laboratory information systems to register maximum increase during the forecast period

Vendors are increasingly capitalizing on developing LIS software for various healthcare verticals

Hospital-grade laboratory information systems are gaining significant momentum

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-875

COVID-19 Impact Analysis

Clinical laboratories are finding it unnerving to cope with the rapid influx of COVID-19 testing samples, impacting their ability to provide accurate testing. Incorporation of automated solutions is therefore anticipated to relieve these clinics of this uncertainty by promoting efficient testing of voluminous samples.

Prominent players in the laboratory information systems landscape are collaborating with public and private sector organizations to employ advanced technologies for implementing COVID-19 testing capabilities. For instance, LabWare Technologies has collaborated with the National Health Service to provide laboratory management software to healthcare settings across the United Kingdom.

Thus, the market shall witness a significant upsurge during the short-term forecast period, with an increasing number of healthcare providers accelerating the uptake of technologically advanced laboratory information systems.

Competitive Intelligence

The global laboratory information systems market is highly fragmented, characterized by the presence of over 50 vendors. Prominent players include: Cerner Corp., Evident, McKesson, Medical Information Technology (MEDITECH), Epic Systems Corporation, SCC Soft Computer, Roper Technologies Inc., CompuGroup Medical and LabWare.

With regard to product launches, Cerner Corporation launched CommunityWorks Foundations, a tailor-made cloud-based technology platform for rural and critical access hospitals in July 2020. This technology shall prove instrumental in reducing overhead costs and reducing lengthy implementation procedures. The platform enables hospitals to maintain electronic health records, reducing immense amount of paperwork.

Recently, in August 2020, Medical Information Technology (MEDITECH) partnered with TECHNATION Health in Canada. This collaboration is aimed at enhancing the privacy and security framework of healthcare providers across the nation, ensuring better patient data security. The solution involves provision of cybersecurity and data sovereignty among other objectives.

Request a Complete TOC of this Report with figures:

https://www.futuremarketinsights.com/toc/rep-gb-875

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com           

[leftcomputerpost]

Home Healthcare Market Will Generate New Growth Opportunities in Upcoming Year

Home Healthcare Market Projected to reach global market revenues of over US$ 4 Bn by the end of 2030, home healthcare continues to receive a strong impetus from a shifting preference for a value-based healthcare delivery model.

Expensive hospital stays, coupled with evolving patient expectations and advancing technologies, are putting immense pressure on healthcare systems to reimagine the way healthcare is delivered over the years. Home-based primary care and hospital-at-home care will continue to make significant strides in the near future, according to a new Future Market Insights (FMI) study on the global home healthcare market.

However, adoption of home healthcare products and solutions has been on a slight decline since Q1 2022 due to evolving priorities of industry amid the global outbreak of COVID-19. Nationwide lockdowns, shutdown of production units, and considerable alternations in supply chains are currently challenging the progress of home healthcare market. The market is however set for a rapid rebound post the containment of coronavirusKey Takeaways of Home Healthcare Market Study

Prevalence of chronic diseases, especially among the geriatric population, is opening a broad array of opportunities for home healthcare companies.

Infusion pumps would remain preferred among various home healthcare products such as pressure relief devices; ostomy drainage bags to follow closely.

Stoma care would be the prominent application area in home healthcare market; key players to invest in IV medication.

North America and Europe continue to offer opportunities of growth and profitability, owing to strong presence of leading players and rising adoption of home healthcare services.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11594

Leading Manufacturers Capitalize on Product Portfolio Expansion and Distributional Partnerships

A majority of companies are focused on development of innovative home healthcare. Several prominent players are investing in expansion of their product portfolio thorough acquisitions in order to extend their geographical reach. For instance, the famous BD and C.R. Bard merger gave rise to a new global healthcare leader. With an aim to expand operations in the UK, Medline had announced opening of its new warehouse in the UK, in 2018.

Some of the prominent players in home healthcare industry that are profiled in the FMI report, include Coloplast A/S, Baxter International Inc, B. Braun Melsungen AG, Hollister Incorporated, ConvaTec Group Plc, Medtronic plc., and Becton Dickinson and Co.

Know More About Report Inclusions

The FMI report brings to fore a comprehensive research on the market growth forecast at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Home Healthcare market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on Home Healthcare market on basis of product type (infusion systems, pressure relief devices, hydrocolloid dressings, hydrofibre dressings, hydrogel dressings, semi-permeable film dressings, superabsorbent dressings, wound contact layers, gauze sponges, gauzes, sponges, ostomy drainage bags), application (total parenteral nutrition (TPN), IV medication, pressure ulcer, stoma care), across seven major regions.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-11594

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.          

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Medical Face Shield Market will grow at over 11% CAGR through 2030

Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights, medical face shields market will grow at over 11% CAGR through 2030.

Medical face shields prove to be an effective means for first line protection against airborne diseases like Zika, SARS, Ebola, flu, and now – Covid-19. As such, increase in adoption of medical face shields, and, in turn, increase in their production is expected to drive the market in the forecast period.

Key Takeaways of Medical Face Shield Market

Polycarbonate remains the material of choice for medical face shield manufacturers

Anti-fog medical face shields likely to witness higher demand than other variants

Disposable medical face shields will outsell reusable, as consumers look to minimize the threat of infection

Sales through online channels likely to offset sluggishness in pharmacies and specialty stores

The IDSA (Infectious Diseases Society of America) has, in its recommendations, included use of PPE (Personal Protective Equipment) like face shields and masks. Though masks have been widely adopted all across, their effectiveness is not that well-known.

The possibility of masks providing marginal protection against virus owing to potential moisture retention, poor filtration, and re-use of cloth masks can’t be ruled out.

On the contrary, face shields are more useful in mitigating respiratory viruses’ transmission like SARS-CoV-2, which would help in minimizing droplets and contacting transmission. However, studies have also pointed out that face shields may not effective in the absence of a masks.

According to Future Market Insights’ analysis, use of medical face shields, used in conjunction with face masks, is being explored, and it is highly likely that sales will soar dramatically in the next six months or so.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11864

Customizable Face Shields Can Become a Reality as Pandemic Lingers On

Medical face shields available in the present scenario are meant for adults. However, child-sized face shields, that too, with interchangeable decorations are being designed now by Metaform Architects for children who have started going back to school.

These masks have been designed for children who fall in the age group of 4 to 8. There are also studs for securing personalized embellishments like googley eyes, animal ears or crowns.

Short-term Spike and Steady Growth in Long Run

According to Future Market Insights’ analysis, the staggering growth in the medical face shield market will be heavily dependent on pharmaceutical interventions to tackle COVID-19. However, even after the availability of a vaccine, it is likely that prevention better than cure approach will drive use.

Learn about more inclusions in FMI’s report

Future Market Insights brings the coming of age research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The global medical face shield market is segmented for covering every aspect of the market and present market intelligence approach in entirety to the reader.

The study provides noteworthy insights on medical face shield market on basis of material (polycarbonate, polyethylene terephthalate glycol, acetate, and propionate) and type (anti-fog, anti-glare and others), usage (disposable and reusable), distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) across seven major regions

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-11864

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Urology Imaging Systems Market is projected to total US$ 486.4 Million by 2028

According to the latest research by the FMI, the global urology imaging systems market is expected to account for over US$ 486.4 Mn, in terms of value, by 2028 end. The report on the Urology Imaging Systems market further projects substantial growth potential with CAGR of 3.7% over 2022-2028.

While hospitals will continue to register the highest revenue share in terms of urology imaging systems adoption, the report highlights limited investment opportunities for manufacturers of urology imaging systems, within clinics.

Increasing EU Reserve Funding Encouraging Adoption of Urology Imaging Systems

Increasing instances of urological disease and simultaneously increasing awareness about critical health issues is anticipated to boost demand for urology imaging systems and services across globe. Accessibility of EU reserves for part states in the CEE, paralleled by administrative projects in Russia, will be an imperative source of financing for new imaging equipment purchases and will contribute fundamentally to the advancement of the urology imaging systems market in the Eastern Europe.

In Russia, the 2020 Healthcare Development Program and National Project ‘Health’ center not just around conveying propelled advances to the nation and furnishing healthcare facilities with costly, top of the line urology imaging systems, yet additionally on obtaining mid-range and low-end urology imaging systems that are very required in local health facilities. The compliance to the EU reserve funding has given access to countries like the Czech Republic, Hungary, Poland, Bulgaria and Romania. Such compliances are anticipated to eliminate barriers for the new entrant in urology imaging systems market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8911

The growing demand for urology imaging systems is centered at increasing inclination towards technologically-advanced imaging tools used in the diagnosis of prostate cancer and uterine fibroid to reduce the risk of uterine cancer. Further increasing demand for urology imaging systems for accurate diagnosis and second opinion is anticipated to create demand for ultrasound- as well as fluoroscopy-based urology imaging systems, thereby driving the growth of the Urology Imaging Systems market. However, ultrasound systems are likely to continue representing a larger market value share over fluoroscopic variants, according to FMI’s analysis.

Favorable Reimbursement Scenario, Supported by Increasing Number of Diagnostic Establishments Driving Market Growth

In the recent years, the number of independent diagnostics and imaging centers in various developed and developing regions has seen a significant spike, overcoming a series of volume and reimbursement pressures in an effort to sustain profitability and achieve better margins. This according to the report is expected to drive the growth of the Urology Imaging Systems market.

Many insurance companies have adopted effective marketing strategies to shift the patient volume to low-cost independent diagnostic centers and reduce the price point associated with urology imaging systems. Independent diagnostic imaging centers offer better service and often of superior quality, generally at the expense of local hospitals and weak operators. The development of low cost portable urology imaging systems is providing leverage to current imagining centers and subsequently driving the growth of Urology Imaging Systems market.

The report tracks strategic developments of some of the prominent players competing in  the global urology imaging systems market, including GE Healthcare, Toshiba Medical, Philips Healthcare, Hitachi-Aloka Medical, Siemens Healthineers, Samsung Medison, Mindray, Fujifilm Sonosite, Esaote, and Analogic. The report also provides key aspects and trends in the Urology Imaging Systems market, including reimbursement scenario, average selling price, and country-wise revenue analysis.

For any queries linked with the report, ask an analyst https://www.futuremarketinsights.com/ask-question/rep-gb-8911

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Pharmaceutical Intermediates Market  rising to 10.2% (578 million) by 2030

According to an analysis by Future Market Insights (FMI), the Hemophilia Treatment Market is expected to be valued at US$ 17.92 Bn in 2032, with a 4.8% CAGR during the forecast period.

Hemophilia therapy has improved dramatically in recent years due to the introduction of new products. In addition, several government and non-government groups are stepping forward to raise awareness of hemophilia symptoms, diagnosis, and treatment.

The high prevalence of hemophilia drives the significant need for quality hemophilia treatment. As a result, several countries are developing creative techniques to improve access to high-quality care for hemophiliacs. For example, innovative methods have been created in Germany to improve the monitoring of these and other associated disorders.

Furthermore, in recent years, awareness of the need for early-stage diagnosis and treatment and its potential impact has increased dramatically throughout European countries, driving demand for a product that would greatly simulate market income. The high prevalence of hemophilia drives the significant need for quality hemophilia treatment.

The high expense of hemophilia therapy, on the other hand, may have a negative impact on market growth. According to the National Hemophilia Foundation, the average cost of hemophilia treatment is over USD 300,000 per year, which has a substantial influence on operation margins, especially in today's capitated reimbursement environment.

The emergence of the COVID-19 pandemic slightly impacted the hemophilia treatment market negatively, owing to disruption in the global supply chain and logistics. Furthermore, the impact of the coronavirus outbreak on the industry peaked during early 2020, wherein patients suffering from such ailments were at a higher risk of suffering from coronavirus as they were more prone to infectious diseases.

Owing to these factors, the hemophilia treatment market is expected to reach US$ 16.5 Bn in 2027.

Key Takeaways:

Hemophilia A, a disease segment accounting for around 82% of the total revenue share, dominated the market in 2021.

In 2021, the adult patient category was worth USD 6,898 million. Hemophilia is becoming more common in the adult population.

In 2021, the prophylaxis segment was worth USD 7,998 million. This preventive medication helps to decrease hemophilic arthropathy and disability and the need for orthopedic surgery, resulting in a better quality of life.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14324

During the forecast period, the injectables segment is predicted to grow at a rate of over 4.9 percent due to the effective method of drug administration.

Competitive Landscape:

Some of the major key players in hemophilia treatment markets are Bayer Healthcare, Biogen, Biotest AG, CSL Behring, Ferring B.V., Genentech, Kedrion, Novo Nordisk, and Octapharma, among others.

Major important players have used advanced technologies to meet the needs of consumers and gain a substantial market share.

Novo Nordisk received FDA approval for its biologics license application for Esperoct in February 2019. This medication is intended to reduce the frequency of bleeding episodes in children and adults with congenital factor VIII deficiency. This launch aided the corporation in introducing new items, giving it a competitive advantage.

Valoctocogene roxaparvovec (valrox) is a novel hemophilia gene therapy treatment developed by BioMarin that eliminates all bleeds and injects blood clotting factor VIII (FVIII) in patients, is expected to get FDA clearance in 2020.

Bayer Healthcare gained FDA approval for a new prolonged half-life hemophilia treatment in August 2018. A product for patients aged 12 and up. Jivi is a rFVIII replacement therapy that has been licensed for the treatment of bleeding. This approval aided the corporation in broadening its product offering globally.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14324

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Sports Medicine Market is set to exhibit robust growth expanding at over 7.5% CAGR between 2022 and 2031

Demand for sports medicines is gaining traction as the sports industry is getting back on track after a temporary period of lull, following the COVID-19 outbreak. According to a study by Future Market Insights, the market will showcase recovery 2021 onwards, a trend which is expected to result in accelerating sales through 2031.

As the requirement for sports medicines for various types such as body reconstruction, body monitoring & evaluation, and others is rising again, the market is projected to record robust growth in the coming years. The latest revised edition of the report on ‘sports medicine’ market study by Future Market Insights (FMI) offers a thorough analysis of the global trends, demand-supply trajectories, and growth & restraining factors for sports medicine suppliers during the forecast period of 2021 to 2031.

According to the report, knee & shoulder injuries will account for the increasing sales of sports medicine while the focus of manufacturers will be on the leading regions such as North America, Europe, and Asia Pacific.

Key Takeaways from Market Study

The global sports medicine market is forecast to expand at over 7.5% CAGR through 2031

High demand for body reconstruction and body support & recovery type of sports medicine to fuel the sales

Rise in application in knee, shoulder, and ankle & foot injuries to cater to the growth of manufacturers

The United States to maintain its lead in the world’s largest sports medicine industry North America

Germany remains dominant in Europe sports medicine industry

Asia Pacific to emerge a highly lucrative market for sports medicine with its epicenters in China and India

Japan, the United Kingdom, Canada, France, Italy, and a few other countries to maintain positive market outlook

“Companies operating in the sports medicines market are focusing on innovations and product launches, besides aiming for certifications from international organizations. There is increasing focus on keeping pace with changing consumer preferences” says an FMI analyst.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5173

Who is Winning?

The global sports medicine market is fragmented and thriving on the key players. In order to sail through the cut-throat competition, key players are launching diverse range of cost-effective products and services. For instance,

Breg Inc. launched its new brand for Orthopedic Service Lines which include OrthoSelect® Consulting, BregBill Programs, Breg Vision® Software, and others on 7th March, 2018

Medtronic Plc. launched its new range of Spinal and Orthopaedic Products and solutions such as T2 Stratosphere, Electrosurgical Products, and others a couple of years back

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Wet Wipes Market is expected to cross  US$ 8.0 Billion by 2031

According to a recent study by Future Market Insights (FMI), the sales of wet wipes are expected to top US$ 3.7 Bn in 2021, growing at a CAGR of over 7.6% during the forecast period (2021-2031).

Increasing health-care related issues and the rising prevalence of infectious diseases and skin-related problems have increased concerns among general population. As a result, awareness with regards to the adoption of personal care and hygiene practices is at all time high.

Regular usage of sanitizer, wet wipes, and tissues for cleanliness and maintaining proper hygiene has positively affected the wet wipes market. With various wet wipes options available in the market, catering to diverse purposes such as incontinence wet wipes- for urinary incontinence, sterile wound cleansing wet wipe- for cleaning wounds, and skin care wet wipe- for regular use; growth prospects for future remains optimistic.

Traditionally, products such as soap, face wash, cleansing milk, and others which are already available in the market have been in use for personal hygiene for generations. But factors such as easy handling, convenience while travelling, achieving cleanliness of hand and face without using water have buoyed consumer inclination in favor of wet wipes.

Companies specializing in wet wipes have been focusing on developing more innovative products such as fragrance- filled wet wipes, environment-friendly, and biodegradable wet wipes and using wood pulp and cotton to avoid harmful effect on sensitive skin.

Government as well as private companies are involved in specialized marketing campaigns to address the need for wet wipes. Furthermore, mergers, acquisitions and collaboration are undertaken by companies to increase the product portfolio as well as reach. All these factors are expected to create demand for wet wipes.

Key takeaways from Wet wipes Market study

By product, incontinence wipes constitute the most lucrative segment in terms of revenue. The demand for incontinence wipes is expected to increase at a CAGR of over 7% 2021-2031.

By disposability, non-flushable wipes segment will hold a revenue share of around 75% in 2021 and is expected to follow the similar growth trend in the future.

By application, skin care wipes segment holds the largest share and will continue to dominate this segment in the forecast period.

In terms of end user, hospitals are leading the market and are expected to gain more than 25% of revenue share over the forecast period.

North America will dominate the global wet wipes market in terms of revenue in 2021, followed by Europe region.

India is dominating the South Asia wet wipes market, accounting for nearly 29% of global market share in 2021.

China holds leading position in East Asia and is expected to account for nearly 40% of market share.

“Steered by changing consumer preference, market players are rethinking sources of materials used for wet wipes manufacturing. Their focus is shifting towards more sustainable and biodegradable options to reduce the burden of wet wipes disposal on the environment. This will present attractive opportunities for growth of the market in the near future,” said a lead FMI analyst.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13751

Who is winning?

Some of the leading manufacturers of wet wipes are focusing on innovative product launches, specialized marketing campaigns, mergers, acquisitions and partnership strategies, thereby enhancing their market presence.

In February 2018, Procter & Gamble Co. announced the acquisition of Snowberry, a New Zealand-based skincare company which specialized in natural ingredient products.

In August 2020, Kimberly-Clark’s brand Pull-Ups launched a product, New Leaf™. Pull-Ups® New Leaf™ is made with plant-based ingredients like sugarcane and fluff pulp, carefully selected and crafted to provide the high level of protection.

In February 2018, Stryker completed the acquisition of Entellus Medical, a medical technology company and strengthen Stryker’s personal care product portfolio.

The key market players covered by FMI include Essity Aktiebolag (publ), Kimberly-Clark, Procter & Gamble, Cardinal Health, Medtronic, Stryker, Coloplast, Hindustan Unilever Ltd., Medline Industries Inc., ConvaTec Inc., The Himalaya Drug Company, Domtar Corporation, Johnson & Johnson Private Limited, Hollister Incorporated and Godrej Consumer Products Limited.

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Vision Care Market is forecast to total US$ 83.72 Billion in 2022

The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems have increased and so is the need for vision care products and services.

According to the latest report published by the company, the global vision care market size is projected to account for over US$ 127,730 Mn, in terms of value, by 2028 end. The report further projects significant growth with an average CAGR of 7.1% through 2028.

Vision Care Market: Dynamics

According to the World Health Organization (WHO), approximately 285 million people are visually impaired worldwide. Out of these, 39 million people are blind and 246 million people have low vision. Most of the disorders & conditions causing visual impairment & blindness are preventable or readily treatable with known & cost-effective interventions, and normal vision can be restored with the help of eyeglasses, contact lenses or refractive surgery. Ageing is one of the prime factors responsible for vision-related problems. Population aged 65+ years is growing day by day and with it the demand for eye care-related products and solutions is also increasing. This increasing ageing population and the growing demand for vision care products are factors expected to create growth opportunities for the manufacturers globally. Healthcare initiatives by the Federal health care programs have increased the number of population opting for vision care benefits. Besides, the out-of-pocket costs have reduced due to insurance coverage. Likewise, in the U.S., “The Patient Protection and Affordable Care Act” has defined eye care for pediatric as an essential benefit. This factor, in particular, is likely to play an instrumental role in driving the growth of the vision care market.

With a rapid increase in the internet usage, technological changes and number of research-based industries, the usage of laptops, mobiles, PCs and others electronic devices has increased in the day-to-day life, which is the major factor responsible for eye-related problems. To overcome this alarming situation, "VISION 2020 - The Right to Sight” a global action program is conducted by NGOs and private organizations in collaboration with the WHO to prevent avoidable blindness. Also, “VISION 2020” has initiated global campaigns to raise awareness among governments about the societal effects of blindness and to gather a strong, long-term political & professional commitment to reduce avoidable blindness. “VISION 2020” has taken initiatives to develop & strengthen the primary health/eye care methodology to prevent the avoidable blindness.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-822

The growth of the vision care market is driven by the increase in lens prescriptions and eye care professionals such as optometrists and ophthalmologists. Most of the ageing consumers (65+) have low awareness regarding eye health. Product development, particularly for the ageing population, is a major challenge as ageing consumers tend to suffer from dry eyes due to which fitting of contact lens becomes difficult. Therefore, the products for ageing consumers need more attention. Elderly population prefers spectacles over contact lens due to low awareness regarding their benefits. According to the company, the spectacle lenses segment accounted over 40% revenue share in the global vision care market in 2017. However, the growing popularity of contact lens might limit the segment’s growth in the near future. Contact lenses offer vision correction for the entire field of the eye including peripheral vision. Soft contact lenses are safe for daily use and for sports as well. They do not fog and can be discarded if damaged. Besides, they are economic compared to prescribed glasses.

Vision Care Market: Regional Insights

In Europe and Northern America, more than 1 person in 5 was aged 60 or above in 2017. According to a survey by the WHO, 90% of the visually impaired population is in low- & middle-income countries. A significant share of this population is unaware regarding the preventive care for vision loss, available curative services and quality rehabilitation. Further, the growing number of ageing population with vision disorders in Asia Pacific is likely to boost the growth of the vision care market in Asia Pacific. Increasing geriatric population and rising disposable income in North America is expected to surge the demand for advanced vision care products and solutions. The North America vision care market is estimated to create an absolute $ opportunity worth US$ 21,735 Mn between 2018 and 2028.

Vision Care Market: Segmental Analysis

The company has segmented the global vision care market into spectacle lenses, contact lenses and cleaning & disinfecting solutions. In terms of revenue, the spectacle lenses and contact lenses segments are expected to hold significant shares over the forecast period. In contrary, the cleaning & disinfecting solutions segment in the vision care market is expected to exhibit limited investment opportunities, in terms of revenue, through 2028.

Vision Care Market: Companies

The report tracks some of the key companies operating in the vision care market, such as Bausch and Lomb (Acq. by Valeant Pharmaceuticals), Alcon (sub. Novartis AG), CooperVision and Johnson & Johnson, LUXOTTICA GROUP, Essilor, ZEISS International, Safilo Group and Rodenstock.

For any queries linked with the report, ask an analyst https://www.futuremarketinsights.com/ask-question/rep-gb-822

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

3D Printed Medical Devices Market is set to experience a significant growth rate of 16.1% CAGR

Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2022- 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways - 3D Printed Medical Devices Market Study

Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.

PolyJet - InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.

Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.

The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Asia Pacific has become the global hub of opportunities, and the leaders in 3D printed medical devices landscape have been eying the opportunity here – owing to the massive application scope, remarkably growing patient population, and relatively less manufacturing costs.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Who Is Winning?

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.

The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Learn More About Report Inclusions

Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022 - 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet - inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Drug Screening Market is projected to expand at a 16% CAGR

As per the Future Market Insights research, the drug screening market is forecasted to advance at a tremendous pace with a CAGR of 16% during the forecast period 2022-2032.

A crucial driver of the drug screening market is the overuse of prescribed drugs and the elevated use of narcotics. According to one of the recent World Drug Reports, drug and alcohol abuse and consumption are on the rise globally.

Drug abuse killed nearly 500,000 people, while drug use disorders resulted in the loss of 18 million years of a healthy life, primarily due to opioids. Similar increases in alcohol consumption have been observed, with the consequences being an increase in the incidence of impaired driving.

The rising consumption of illicit drugs and alcohol will accelerate the development of drug screening products and services on the road, fuelling the drug screening market growth.

Some countries, including South Africa, Colombia, Chile, Argentina, and Canada, consider workplace drug and alcohol testing to violate employee privacy. Such prohibitions in various countries may impede the adoption of drug screening devices etc., thereby limiting the overall market growth.

Several new products, devices, and services have also received regulatory approval and are being adopted by government agencies and corporate organizations and are expected to broaden drug screening market opportunities.

Companies in this market are expected to gain new opportunities as their business strategies shift toward oral swab drug tests and the development of the concept of fingerprint-based drug screening, thereby driving the demand for drug screening devices etc.,

Furthermore, New Psychoactive Substances (NPS) such as tryptamines, ketamine, piperazine, and phenethylamines can be considered emerging trends in the drug screening market. Owing to its low cost and dependability, urine samples are the most commonly used for testing, ramping up urine drug tests.

Influenced by factors as mentioned earlier and developments, the drug screening market is forecasted to touch US$ 11 Bn by 2026.

Key Takeaways:

By product type, the consumables segment is likely to dominate the market since they provide improved solutions to make testing accurate and quick, accelerating market growth.

As it is a quicker and less invasive sample to collect at the roadside, the oral fluid sample segment is expected to account for a significant drug screening market share by sample type.

By drug type, the cannabis/marijuana segment is forecasted to hold sway over the drug testing industry since marijuana or cannabis is the most commonly used illicit substance in critical markets.

Drug testing laboratories are predicted to be at the forefront of the market by end-use, owing to their widespread acceptance and accurate result.

The drug screening market size accounted for around US$ 5.3 Bn in 2021.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14265

"North America is projected to reign the market owing to the government implementing strict workplace testing regulations as well as expansion strategies followed by players. Furthermore, the region's high adoption of technologically advanced solutions & favourable reimbursement scenarios has fuelled the market growth. New organ-on-a-chip platforms enable more precise and accurate perception of drug effects on the human body, and its advancements are also contributing to the growth of the North American drug screening market." asserts an FMI researcher.

Competitive Landscape:

Some of the notable players in the drug screening market are Premier Biotech (US), Abbott Laboratories (US), Alfa Scientific Designs (US), OraSure Technologies (US), Shimadzu (Japan), Drägerwerk (Germany), LifeLock (US), Thermo Fisher Scientific (US), MPD Inc. (US), Omega Laboratories (US), Psychemedics (US), Roche (Switzerland), and Siemens Healthineers (Germany), Quest Diagnostics (US).

To capture larger market shares, key companies are pursuing various growth strategies such as mergers and acquisitions, geographic expansion, product invention leading to some significant recent developments in the drug screening market.

Drager Safety Canada's Drager drug test 5000 drug testing device received government approval, making it the country's first roadside oral fluid drug testing device with active government support.

Intelligent fingerprinting limited, based in the United Kingdom, has released the world's first portable fingerprint drug test to detect and analyze marijuana, opiates, and amphetamines. The newly launched device allows for sample collection and analysis in 10 minutes, speeding up the process.

For any queries linked with the report, ask an analyst https://www.futuremarketinsights.com/ask-question/rep-gb-14265

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Aspiration & Biopsy Needles Market is estimated to reach US$ 1.29 Billion by 2026

The aspiration and biopsy needles market is forecasted to be worth US$ 0.87 billion in 2021, with a CAGR of 7% forecast to hit US$ 1.83 billion by 2032.

Many growth-promoting factors are driving the aspiration and biopsy needles market, along with rising demand for minimally invasive surgeries, greater cancer awareness campaigns by global health organizations and governments, and rising cancer diagnoses.

Cancer screening, cancer management visits, and cancer biopsy procedures have all decreased significantly due to the COVID-19 pandemic. In addition, cancer screening operations were hampered due to the lockdowns, resulting in a reduction in demand for biopsy needles.

Since March 2020, COVID-19 has resulted in a substantial drop in imaging operations (for all modalities).

The aspiration and biopsy needles market players have an opportunity to expand their presence in the unexplored aspiration and biopsy needles market of emerging nations. For example, in the Middle East and Asia-Pacific, the senior population and cancer prevalence rapidly rise, yet biopsies are mostly administered using the standard surgical approach.

Emerging economies such as India, China, and South Korea provide market participants with high-growth potential. As a result, the Asia Pacific market is predicted to grow at the fastest CAGR during the forecast period.

The driving factors of the aspiration and biopsy needles market are fueling the global of this regional aspiration and biopsy needles market are increased government initiatives for cancer diagnostics and screening, increased research activities, and the high incidence of cancer in significant Asia Pacific countries such as India and China.

As a result, enterprises in the area have begun merging several imaging modalities to improve the operation and lower the cost for patients. Furthermore, as individuals in this country become more informed about efficient cancer diagnostic procedures, aspiration and biopsy needles market manufacturers have the potential to expand by focusing on developing-country clients.

"India is facing an acute shortage of oncologists, radiotherapists, and surgical oncologists. With 1.8 million cancer patients in the country, there is only one oncologist to treat every 2,000 patients."

Radiologists and surgeons use biopsy needles to examine abnormalities at a specific site. Since these treatments include cuts and incisions for obtaining tissue samples, patients may become infected. In addition, aspiration and biopsy needles are frequently reused, which raises the risk of infection during these operations. Although the reuse of biopsy needles is discouraged by healthcare authorities and product manufacturers, the practice persists, particularly in underdeveloped nations.

Key Takeaways:

By 2026, the global aspiration and the biopsy needle are estimated to reach US$ 1.29 billion.

Core needle biopsy (CNB) is the most common type of biopsy, accounting for over 47% of the total aspiration and biopsy needle market in 2019.

Hospitals accounted for 74.3% of the entire aspiration and biopsy needle market in 2019.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14287

North America is the world's largest consumer area, accounting for 35.2% of worldwide aspiration and biopsy needle market sales in 2019.

Europe is a significant consumer aspiration and biopsy needle market, accounting for 30.46% of worldwide sales.

Vacuum-assisted biopsy, biopsy guns, and biopsy forceps and punches will all develop at far faster rates than Fine Needle Aspiration, with CAGRs of 3.97 percent, 3.70 percent, and 1.63 percent, respectively.

Competitive Landscape

To expand their portfolio and streamline the competition, manufacturers in the aspiration and biopsy needles market have acquired other companies in recent years.

Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Stryker Corporation, Becton, Dickinson and Company, Argon Medical Devices Inc., CONMED Corporation, Merit Medical Systems Inc., Sterylab s.r.l., Cook Medical LLC, and Cardinal Health Inc. are among the significant global aspiration and biopsy needles market manufacturers.

The following are some noteworthy developments in this aspiration and biopsy needles market's competitive landscape:

In September of last year, Olympus Corporation of Tokyo gained FDA certification for its EZ Shot Plus 25 G needle.

Olympus Corporation, based in Tokyo, introduced aspiration biopsy needles with Side Port - Reusable to the market in April 2016. (NA-2C-1)

In the United States, Cook Group Incorporated released the EchoTipProCore 20 Gage Needle a few years ago. It was designed for fine needle biopsy with ultrasound guidance (FNB).

In January 2021, Hologic, Inc. acquired SOMATEX Medical Technologies GmbH, a leader in biopsy site biomarkers, for USD 64.00 million. The acquisition funds Hologic, Inc.'s strategy to deliver a varied range of novel solutions for breast cancer treatment. Hologic, Inc. would be able to expand the breast cancer marker portfolio.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14287

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

In Vitro Fertilization Market is projected to grow at a rate of 9% CAGR during the forecast period of 2022 to 2032

From US$ 640 Million in 2021, the global in-vitro fertilization market is expected to reach US$ 1.6 Billion by 2032, with a Compound Annual Growth Rate (CAGR) of 9% predicted from 2022 to 2032.

Rising reprotourism and increasing incidences of male and female infertility are two key factors driving in vitro fertilization/IVF market growth. Infertility is a critical health problem that affects people from around the world.

According to the American Pregnancy Association, male infertility accounts for 30% of infertility cases and leads to about one-fifth of infertility cases. The market will rise as people become more dependent on fertility treatments. The growing use of in vitro fertilization (IVF) techniques is being influenced by the availability of resources.

The emergence of the COVID-19 pandemic prompted the cessation of fertility treatments, which had a psychological impact on the women who had their treatments discontinued. Treatment clinics are now allowed to resume treatments under the condition that they observe stringent requirements.

Culture medium, capital equipment, and IVF disposable devices make up the in vitro fertilization instrument. In 2020, culture media dominated the in vitro fertilization/IVF market and accounted for a large portion of the income. The availability of money and an increase in research initiatives to improve the culture media were credited with in vitro fertilization/IVF market expansion.

The disposable devices market, on the other hand, is predicted to increase at the quickest rate over the projection years, as the in vitro fertilization/IVF market participants provide disposable devices such as needles, slides, and chambers to fulfil sterility and regulatory criteria.

The sector of fertility clinics led the global the in vitro fertilization/IVF market, accounting for the majority of revenue. Throughout the projected period, the category is expected to maintain its leading the in vitro fertilization/IVF market position while increasing at the highest rate.

The rise of fertility clinics is expected to be fuelled by factors such as cost-effectiveness, availability of experts, and little or no risk of Hospital-Acquired Infections (HAIs). IVF procedures are also carried out in hospitals.

In 2020, the frozen non-donor segment dominated the global in vitro fertilization/IVF market. However, in 2020, the fresh non-donor sector had the second-highest revenue in vitro fertilization/IVF. The significant proportion of this category is due to the higher success percentage on the first try.

Some of the in vitro fertilization/IVF market's latest advancements include disposable slides for sperm counting, an imaging-based monitoring system to extract the best motile sperm, and the usage of disposable microchips.

During the projection period, Asia-Pacific is expected to be the fastest-growing in vitro fertilization/IVF market. The in vitro fertilization/IVF market is being driven by several causes, including rising ovulation disorders in women, rising trends in assisted reproduction technologies, and rising rates of infertility. In addition, government programmes for fertility therapy are projected to provide in vitro fertilization/IVF market development opportunities.

Key Takeaways:

In 2020, culture media dominated the in vitro fertilization/IVF market, accounting for more than 41% of total sales.

In 2020, Europe dominated the worldwide in vitro fertilization/IVF market with a revenue share of about 37%.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14305

In 2020, the frozen non-donor category accounted for more than 47% of the total in vitro fertilization/IVF market sales.

In 2020, the fertility clinics sector led the global in vitro fertilization/IVF market, accounting for more than 79% of total revenue.

"Boost in productivity tourism, a rise in the number of fertility clinics, and the lower cost of IVF procedures in emerging countries compared to developed countries are expected to provide lucrative market expansion opportunities."

Competitive landscape:

CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. are some of the major competitors in the in vitro fertilization/IVF market. These in vitro fertilization/IVF market participants use a variety of marketing techniques to grow their in vitro fertilization/IVF market share, including mergers and acquisitions, product launches, and regional expansion.

Royal Philips and Merck KGaA announced a multi-year collaboration in January 2021 to explore digital solutions for individualized reproductive treatments.

Merck KGaA got European Commission (EC) Marketing Authorization (MA) in January 2020 for its novel GONAL-f (follitropin alfa) 150 IU pen, which is intended for patients from the start to the conclusion of their reproductive stimulation cycle and requires lesser dosages.

TMRW Life Sciences said in February 2021 that it had created the world's first automated frozen specimen management system for IVF embryos and eggs. TMRW's proprietary platform has been placed in a number of top reproductive clinics throughout the United States, ushering in a new era of integrated, software-enabled administration of the millions of eggs and embryos that are at the heart of modern IVF. The firm is expanding internationally, and it has announced that by the summer of 2021, it will be in UK-based reproductive clinics.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-14305

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.            

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Artificial Airway Holders Market Market  Important Changes in Industry Dynamics during 2022-2028

Artificial Airway Holders Market Overview

Artificial Airway Holders: Market Insights

Artificial Airway Holders are used to provide fixation support to endotracheal and tracheostomy tubes, which are used to establish a secure air pathway in patients requiring mechanical ventilation or those who are at risk of aspiration. Artificial airway holders is associated with minimized tube movement and displacement in comparison to the conventional ones such as tying through tapes during transportation of intubated patients or during chest compression. Artificial airway holders is equipped with a quick-fix screw for a quick and safe fixing of either single or more ventilation tubes. Artificial airway holders also facilitates integration of bite block, large opening for suction of liquids, and sterile enough to prevent contamination. Some features associated with the artificial airway holders include quickly connect ratchet system allowing easier and safe fixation of endotracheal and tracheostomy tubes, after it has been inserted into the trachea. Artificial airway holders contain a bite block protruded to ensure no extra equipment is required for the intubation.

Amongst different varieties of the artificial airway holders available in the market, the disposable ones made of up latex-free materials are floating in the market as it minimizes the chances of infection during airway management. Hospitals dominates the usage of artificial airway holders due to high patient turnaround that demands large surgical procedure volumes. Successful operative procedures in the airway management involving usage of artificial airway holders makes the respective market to flourish. In many ways, government initiatives and training programs, are scheduled frequently to generate awareness and safety amongst individuals and healthcare providers. It also serves as driving factors toward the substantial growth and use of artificial airway holders in the air way management device market.

Artificial Airway Holders: Market Dynamics

Artificial airway holders are used to establish a more secure airway in patients requiring either mechanical ventilation or at risk of aspiration. Increase in medical treatment involving surgeries, respiratory diseases, trauma and geriatric population have increased Artificial Airway Holders demand, as it provides support to the endotracheal and tracheostomy devices. In addition, increased awareness of preventive therapeutic programs by various healthcare agencies across the world, is anticipated to drive the growth of the artificial airway holders market. However, in certain low income or underdeveloped nations, their government’s stringent regulations with respect to devices price, safety and efficacy will hinder the growth of artificial airway holders market. Also, presence and usage of alternative substitutes like adhesive tapes and adhesive may significantly alter the market of artificial airway holders. Ongoing R&D activities related to artificial airway holders are anticipated to present new opportunities for the betterment of the market. In competitive landscape, the artificial airway holders market comprises of a large number of both global and regional players, making the market highly competitive as well as scattered in nature. In order to succeed in such competitive environment, the manufacturers have already started to focus on expanding their product portfolio and footprint, developing innovative products, investing in R&D researches, expanding footprint in in emerging nations, and improving brand recognition in artificial airway holders market. In addition, several major manufacturers of artificial airway holders are floating investments to acquire small and local companies.

Artificial Airway Holders Market: Overview

Artificial Airway Holders are airway medical equipment used for a secure fixation and support of both the endotracheal and tracheostomy tubes. Artificial Airway Holders are as such devices that helps to overcome complexities arising from improper extubations, pressure arising from sores, and damages to the skin. Demand of Artificial Airway Holders in the market is driven by the increase in diseases associated surgeries, trauma incidences and rise in geriatric population. Ongoing R&D activities related to air aid endotracheal tube holder are anticipated to present new opportunities for the artificial airway holders market. The market is segmented on the basis of product type, end-user, and geography. Based on product type, the market is bifurcated into metal and polymer. By end-user, it is classified into hospital, special clinics, ambulatory surgical centers and medical centers.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7314

Artificial Airway Holders Market: Key Players

Some of the key players present in global artificial airway holders market include B&B Medical, Dale Medical, Hollister INC, Neotech Products, Precision Medical, Ambu, Medline Industries INC, Smiths Medical ASD, Precision Medical, Teleflex Medical and Vyaire Medical, Inc and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-7314

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Hemorrhagic stroke Treatment Market  - Future Scenario, Key Insights, Top Companies 2028

Hemorrhagic stroke Treatment Market Overview

A stroke is a recurring condition which happens when there is imbalance in the blood supply to the brain either because of rupture of blood vessels or a blood clot, which can lead to mortality of cerebrum cells or a brain death. A hemorrhagic stroke happens when the blood loss is inside brain, sudden bleeding which occurs within the brain or between the brain and the skull bone, although hemorrhagic stroke holds higher mortality rate compare to other type of strokes. Hemorrhagic stroke Treatment usually involves monitoring and lowering the blood pressure. The Hemorrhagic stroke Treatment also constitutes surgical intervention to lower the blood pressure, typically a devices known as ventriculostomy tube is inserted into the ventricle and drainage of blood from the brain is achieved. The Hemorrhagic stroke Treatment facilitate rapid recovery and elimination of further damage to the brain. The minimal risk of surgical intervention in surrounding of the brain is achieved through the use of technique called “burr hole” by Hemorrhagic stroke Treatment. Additionally, the haemostasis is achieved with the help of endovascular repair. The time required in receiving Hemorrhagic stroke Treatment plays a major role in survival of hemorrhagic stroke patient. The Hemorrhagic stroke Treatment offers primal advantage in selection of procedures and drugs according to the severity of the hemorrhagic stroke condition.

Hemorrhagic stroke Treatment Market: Drivers and Restraints

The major driving factor for Hemorrhagic stroke Treatment market is increasing in incidences of stroke, owning to the lifestyle changes and increasing burden of chronic diseases. As per American stroke association hemorrhagic stroke accounts for approximately 14-20 percent of stroke cases. Wherein about 33% to 65% of people affected with intracerebral hemorrhage leads to death. The rise in new incidences of chronic diseases drives the hemorrhagic stroke treatment market. Furthermore, the growing consumption of anti-hypertensive drugs also increases the chances for hemorrhagic stroke subsequently increasing the demand for hemorrhagic stroke treatment. The primary advantage of therapeutic based Hemorrhagic stroke Treatment is shorter onset of action and recovery time which in case of Hemorrhagic stroke Treatment results in survival of the patient. The shorter onset of action of hemorrhagic stroke therapeutic drugs is expected to drive market for Hemorrhagic stroke Treatment market. The increasing prescription rate of antihypertensive drugs by physicians and high clinical effectiveness of Hemorrhagic stroke Treatment is anticipated to expand the market for Hemorrhagic stroke Treatment. Increasing number of patients with ischemic stroke coupled with increasing consumption of tobacco is anticipated to increase the risk of hemorrhagic stroke, thereby it is anticipated to propel the market for Hemorrhagic stroke Treatment. However, rigid regulatory guidelines for drugs used in hemorrhagic stroke treatment coupled with high cost of treatment is anticipated to restrain the growth of the Hemorrhagic stroke Treatment market.

Hemorrhagic stroke Treatment Market: Overview

The global Hemorrhagic stroke Treatment market is anticipated to show exponential growth as it offers primary care and treatment for hemorrhagic stroke. Due to increasing demand of non-invasive procedure for various surgeries and disease conditions is anticipated to drive the demand for Hemorrhagic stroke Treatment market. Specifically, therapeutic Hemorrhagic stroke Treatment is anticipated to show higher growth rate. In the upcoming years, the global Hemorrhagic stroke Treatment market is anticipated to witness the entry of new market players which would increase market competition in the Hemorrhagic stroke Treatment market. Obesity is one of the most common reason for hypertension and stroke in the world, especially in case of obese diabetes patient. Hence, with the rapidly growing global population, primarily adult male and female population who are more vulnerable to have a hypertension and diabetes, thereby the market for Hemorrhagic stroke Treatment is expected to increase at a steady rate. The recent technological advancement in Hemorrhagic stroke Treatment surgeries such as craniotomy and Endovascular repair (using coils and stents) is expected to bring further competition in the Hemorrhagic stroke Treatment market.

Hemorrhagic stroke Treatment Market: Regional Outlook

Geographically, the global Hemorrhagic stroke Treatment market is segmented into regions viz. North America, Latin America, CIS & Russia, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is estimated to be the dominant market in the global Hemorrhagic stroke Treatment market owing to technological advancement and specialty healthcare infrastructure. The Hemorrhagic stroke Treatment market in the Asia Pacific excluding Japan is expected to grow significantly due to the increasing product launches and recent rise in healthcare standards in China and India. Europe is expected to hold the second largest share in the global Hemorrhagic stroke Treatment market throughout the forecast period owning to the increase in incidence of stroke.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7884

Hemorrhagic stroke Treatment Market: Key Players    

The global market for Hemorrhagic stroke Treatment is fragmented with large number of market players. Examples of some of the primary key players operating in the global Hemorrhagic stroke Treatment market are B. Braun Melsungen AG,  Abbott Laboratories, Merck & Co., Pfizer Inc., Novartis AG, Sanofi S.A.,  Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Daiichi Sankyo Company Limited, Astra Zeneca Plc, Glaxosmithkline Plc., Medtronic Plc. etc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers an exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Mexico, Brazil, Argentina, Chile, Peru, rest of Latin America)

Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)

CIS & Russia

Asia Pacific excluding Japan (Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)

Japan

Middle East and Africa (GCC, S. Africa, Turkey, Iran, Israel, Rest Of MEA)

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-7884

bout FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Analytical Ultracentrifuge Systems Market Key Opportunity, Analysis, Growth, Trends 2028

Analytical Ultracentrifuge Systems Market Overview

Analytical ultracentrifugation is the rigorous as well as most accurate technology available for the determination of thermodynamic and hydrodynamic properties of proteins or other macromolecule. Analytical ultracentrifuge systems also let’s determine shape, diameter, mass, stoichiometry, purity and other differentiating properties of the macromolecules which are difficult to separate otherwise. Various biopharmaceutical companies use analytical ultracentrifuge systems to check the homogeneous nature of the solution mixture with proteins. By examining the homogeneity of the mixture analytical ultracentrifuge systems helps in maintain the purity of the mixture for the better biopharmaceutical related usage. Other methods which are used for the examination of thermodynamic and hydrodynamic properties such as chromatography or electrophoresis are more prone to errors as compared to analytical ultracentrifuge systems.

Analytical Ultracentrifuge Systems Market: Drivers and Restraints

Increasing use of biopharmaceuticals for the treatment of chronic diseases such as cancer, diabetes, arthritis and others expected to drive the growth of the analytical ultracentrifuge systems market. Day to day evolving nature of managing life threatening illness and increasing availability various options such as biologics for treatment majorly impacts the analytical ultracentrifuge systems market. The advanced nature of analytical ultracentrifuge systems as compared to other available systems give an extra edge ahead to analytical ultracentrifuge systems fueling the growth of the market. Current drug market is dominated by the small molecules but increasing research in the macromolecule sector for the therapeutic usage also responsible for the surge in the analytical ultracentrifuge systems market. The tedious process of examination and purification of proteins due to their complex structure and high molecular weight further increasing adoption of advanced methods such as analytical ultracentrifuge systems for the task. Increasing research and development funding by the biopharmaceutical companies further increasing the volume of studies taking place driving the growth of the analytical ultracentrifuge systems market.

Analytical Ultracentrifuge Systems Market: Overview

Increasing biopharmaceutical production due to increasing usage of biologics for the therapeutic use is the major factor in the analytical ultracentrifuge systems market growth. The analytical ultracentrifuge systems market by application is expected to be dominated by the protein analysis due to increasing research and production associated with protein molecules. By end user, analytical ultracentrifuge systems market is expected to be dominated by the biopharmaceutical companies due to rapidly increasing production and increasing spending on research and development. The manufacturing companies in the analytical ultracentrifuge systems market are focusing on the development of advanced and more easy to use analytical ultracentrifuge systems for the research purpose.

Analytical Ultracentrifuge Systems Market: Regional Outlook

By region the global analytical ultracentrifuge systems  market is segment in to North America, Latin America, Western Europe, Western Europe, Eastern Europe, Asia-Pacific excluding China, China and Middle East & Africa. The global analytical ultracentrifuge systems market is expected to be dominated by the North America due to high number of the biopharmaceutical companies in the region and increasing research and development around biologics. Europe is expected to be the second most lucrative analytical ultracentrifuge systems market due to large number of biopharmaceutical companies in the region. Latin America is expected to witness steady growth due to increasing biopharmaceuticals in the region. Asia-Pacific is expected to be the fastest growing analytical ultracentrifuge systems market due to rapidly improving healthcare infrastructure and emerging countries such as India and China. Middle east & Africa expected to remain least lucrative analytical ultracentrifuge systems market due to low biopharmaceutical companies in the region.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8062

Analytical Ultracentrifuge Systems Market: Key Players

Some of the global key participants operating in analytical ultracentrifuge systems market are: Beckman Coulter, Inc., Spin Analytical, NuAire, Eppendorf AG, Thermo Fisher Scientific, Hanil, Helmer Scientific, Hettich Instruments, LP, HighRes Biosolutions, IKA laboratory technology and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Indication

Value Chain

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)

Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For any queries linked with the report, ask an analyst >>

https://www.futuremarketinsights.com/ask-question/rep-gb-8062

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Plant Derived Proteins Market rising at a remarkable CAGR of 8.4%over the forecast period(2022-2029)

Production and commercialization of biopharmaceutical proteins with higher therapeutic efficacy have formed a progressive landscape that continues to push the growth of plant derived proteins market. A new Future Market Insights (FMI) report forecasts that the plant derived proteins market will experience a major upturn towards 2029, reaching a value of around US$ 185 Mn. Production of three main therapeutic protein classes, including antibodies, vaccines, and replacement proteins such as albumin, insulin, growth factors, and cytokines will remain industry’s prime focus area. Plant derived proteins are recognized as natural and environmentally-sustainable than microbial and mammalian cells. Owing to these benefits, there has been an increasing demand for such proteins from biopharmaceutical companies, as raw materials for therapeutic drug production, creating an absolute opportunity for growth of the plant derived proteins market.

Key Takeaways of Plant Derived Proteins Market Study

The production of therapeutic proteins for disease treatment will gain traction, contributing more than 70% to global market revenues in 2029.

Owing to low setup cost, transient plant expression systems (carrot or tobacco) remains preferred among protein manufacturers.

Regenerative medicine-therapeutic agents continue to be the leading application area, on the back of their relatively cheap price point.

Biopharmaceutical companies represent the leading consumer industry of plant derived proteins, with over 50% share in market throughout the forecast period.

North America continues to lead, whereas East Asia holds the promise of lucrative opportunities, owing to several healthcare programs.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11038

Acquisition Key Strategy Followed by Leading Market Players

Leading manufacturers in the plant derived proteins market are focusing on regional acquisition strategy to enhance their product portfolio and expand their regional presence.  For instance, in 2020, Denka buys pharming pioneer Icon Genetics, which is a leading manufacturers of therapeutic proteins in plants. In 2014, Kentucky BioProcessing, Inc. was acquired by Reynolds American Inc., which is a wholly owned subsidiary of tobacco manufacturing company British American Tobacco plc.

Interested in more insights on the build-up of plant derived proteins market?

Plant derived proteins market, a new study from future market insights, opines on the production of plant derived proteins from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; plant type (tobacco, carrot, rice, barley and others), protein type (industrial proteins & enzymes, therapeutic proteins cell culture functional proteins and others), application (regenerative medicine-therapeutic agents, regenerative medicine-functional material, cell culture application and others), platform (in-vitro culture system, whole plants and others) and end user (biopharmaceutical companies, academic & research institutes, contract research organization (CROS), contract manufacturing organization (CMOS)) across seven prominent regions.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11038

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[leftcomputerpost]

Pericarditis Treatment Market Prospects and Growth Assessment 2028

Pericarditis Treatment Market Overview

Global Pericarditis Treatment: Market Insights

Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial infections and intake of some drugs such as procainamide.

Some of the common symptoms of pericarditis disease are shortness of breath, fatigue, rapid or abnormal heart rhythms, and chest pain. Global Pericarditis treatment includes therapeutic treatment and surgical treatment. Acute pericarditis can be treated by medication for pain and inflammation, such as aspirin and ibuprofen. Depending on the cause of the pericarditis disease, several antifungal medications are prescribed which are expected to hold the maximum revenue in the pericarditis treatment market. In case of chronic or recurrent pericarditis, anti-inflammatory drugs such as colchicine are prescribed for pericarditis treatment. If the patient suffering from pericarditis disease does not show any response to the anti-inflammatory drugs, they are prescribed with corticosteroids such as prednisone.

Apart from medications, there are other surgical methods of treatment in pericarditis treatment market which are needed in the patients especially when all the other medical treatment fails.

Global Pericarditis Treatment: Market Dynamics

Increase in the prevalence rate of cardiovascular diseases across the globe is the major growth driver of Global Pericarditis Treatment Market. The growing geriatric population is also responsible for the growth of pericarditis treatment market. Increase in smoking, alcohol consumption, and lifestyle changes are the major factor behind the growth in cardiovascular diseases and also contributing factor for the growth of the pericarditis treatment market. More focus on the prevention and treatment of cardiovascular diseases in low- and middle-income economies is expected to drive the growth of the market for Pericarditis treatment. Increasing healthcare expenditures is also expected to fuel the global pericarditis treatment market.

Lack of awareness and the high cost of surgeries are the major factors which can hamper the growth of the Global Pericarditis Treatment Market.

Global Pericarditis Treatment Market : Overview

Pericarditis treatment has been segmented into therapeutics and surgery. Pericarditis therapeutics include medication for pain and inflammation, such as aspirin and ibuprofen. Antibiotic or antifungal medicines are majorly used to treat the pericarditis disease and are expected to hold the maximum revenue share in the global pericarditis treatment market. Anti-inflammatory drugs such as colchicine are also used for the treatment of pericarditis disease.

Surgery is not a usual way of treatment and they are adopted only if the other methods of treatment are not successful.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8922

Global Pericarditis Treatment Market: Region-wise Outlook

On the basis of geography, Global Pericarditis Treatment Market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is expected to hold largest shares in the Pericarditis Treatment Market primarily due to the presence of a large number of hospitals and high-quality healthcare infrastructure. North America has a high number of laboratories for clinical research, therefore, is expected to drive the global pericarditis treatment market. Europe is expected to show the second highest share in Pericarditis Treatment market due to high prevalence of cardiovascular diseases. The Asia Pacific is also expected to hold a large revenue share in the global pericarditis treatment market due to the presence of a large population and a huge occurrence of cardiovascular diseases.

Global Pericarditis Treatment Market: Key Players

Global Pericarditis treatment market has many key players. Major international manufacturers leading Pericarditis Treatment Market are Pfizer Inc., Bayer AG, PerkinElmer Inc., ALLERGAN, Lincoln Pharmaceuticals Ltd., Unicure India Pvt. Ltd., Zydus Cadila Healthcare Ltd., Twilight Mercantiles Pvt. Ltd.,Aasraw Biochemical Technology Co.ltd, Sun Pharmaceutical Industries Ltd.

The report covers exhaustive analysis on:

Pericarditis Treatment Market Segments

Pericarditis Treatment Market Dynamics

Pericarditis Treatment Market Size

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

The regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)

Japan

The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-8922

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com